BiondVax Pharma Reports Q2 Loss of $3.7M
- ByInvesting.com-
BiondVax Pharmaceuticals Ltd. (BVXV), which focuses on developing, manufacturing and commercializing innovative products for the prevention and treatment of infectious diseases and...